TacticScaleWhat Acadia Healthcare Does & How It Makes Money (ACHC)
Updated October 2026 · reflects Acadia Healthcare's latest reported financials
U.S. operator of behavioral health and addiction treatment facilities. It owns and operates behavioral healthcare facilities and earns revenue by providing inpatient, residential, and outpatient treatment services to patients.
How Acadia Healthcare makes money
It owns and operates behavioral healthcare facilities and earns revenue by providing inpatient, residential, and outpatient treatment services to patients.
What Acadia Healthcare does
Acadia Healthcare is a U.S.-based operator focused only on behavioral healthcare, meaning treatment for mental illness and addiction. Its facilities cover several levels of care: acute inpatient psychiatric hospitals, residential recovery and eating disorder programs, comprehensive treatment centers, residential treatment centers, and outpatient services. Founded in 2005 and headquartered in Franklin, Tennessee, the company operates in the United States and Puerto Rico. It is a facilities-based healthcare provider in the medical care facilities industry, and its revenue depends on patient demand for psychiatric and substance use treatment.
Products & services
- Acute inpatient psychiatric facilities
- Residential recovery (addiction treatment) facilities
- Eating disorder treatment facilities
- Comprehensive treatment centers
- Residential treatment centers
- Outpatient behavioral healthcare services
What is Acadia Healthcare worth?
On an owner-earnings DCF, Acadia Healthcare's most-likely value is about $20 versus a recent price near $29 (31% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$11) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 19.6× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
ACADIA Pharmaceuticals (ACAD) · Acadia Realty Trust (AKR) · Acadian Asset Management (AAMI) · HCA Healthcare (HCA) · Universal Health Services (UHS)